A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects
Clinical trial NCT00656097 · COMPLETED
Trial details
- NCT number
- NCT00656097
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2008-07-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.